| Serial Number | 79393467 |
| Word Mark | NX |
| Filing Date | Thursday, February 15, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, April 2, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Recorded computer programs for use in oncology for analysing tissue samples from patients; downloadable computer programs for use in oncology for analysing tissue samples from patients; downloadable software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; downloadable software for the digital representation of tumors and tumor features; software for the digital representation of tumors and tumor features; downloadable software for high- resolution digital image representation of the molecular composition of cellular anomalies; recorded software for high-resolution digital image representation of the molecular composition of cellular anomalies; downloadable software for high- resolution digital image representation of a digital tumor; recorded software for high- resolution digital image representation of a digital tumor; downloadable software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; recorded software for the analysis of medical data, particularly for cancer research, treatment and diagnosis |
| Goods and Services | Diagnostic preparations for medical purposes; diagnostic radiopharmaceutical preparations for medical purposes; pharmaceutical products, medical and veterinary preparations, namely, pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for the diagnosis and treatment of cancer; diagnostic pharmaceutical preparations; medical test kits comprising pharmaceutical preparations for individual medical diagnosis for cancer therapy; medical test kits comprising pharmaceutical preparations for use in oncology for cancer screening; medical test kits comprising pharmaceutical preparations for cancer diagnosis; medical test kits comprising pharmaceutical preparations for individual medical diagnosis in the field of protein imaging; Diagnostic test kits for use in oncology comprising pathology slides for testing tissue samples; test kits for use in oncology comprising sample tubes for testing tissue samples; diagnostic test kits comprising laboratory equipment for sample preparation, processing and storage for cancer diagnosis; diagnostic test kits for individual medical diagnosis comprising sample collection equipment for tumour analysis |
| Goods and Services | Diagnostic biomarkers for analytical, research and scientific use; diagnostic biomarkers for in vitro testing for scientific use; diagnostic biomarkers for use in assessment of genomic analysis for scientific use; diagnostic biomarkers for use in assessment of individual diagnoses of cancer; diagnostic preparations for science or research; diagnostic reagents for science or research diagnostic reagents for the diagnosis of diseases; chemicals for the production of medical diagnostic reagents, particularly for cancer research |
| Goods and Services | Pharmaceutical and medical consulting, particularly in the field of medical diagnostics and oncology; pharmaceutical and medical consulting for businesses in the medical and medical diagnostics field; pharmaceutical and medical consulting for cancer treatment; disease diagnosis services; cancer diagnosis services, particularly for enabling personalized and individual medical care; disease diagnosis services, particularly in the field of oncology; disease diagnosis services in the field of proteomics; medical analysis services for cancer diagnosis and prognosis; remote monitoring of medical data for medical diagnosis; medical analysis for the diagnosis and treatment of persons; remote monitoring of medical data for medical diagnosis and treatment; medical testing services relating to the diagnosis and treatment of disease; providing information in the field of cancer prevention, screening, diagnosis and treatment; medical diagnosis and treatment of cancer; testing and analysis services being medical diagnostic services; medical diagnostic services for the indication of individual treatments; medical diagnostic services for the indication of individual cancer treatments; medical diagnostic services for the indication of individual treatments in the field of oncology; providing information concerning diagnostic, prophylactic and therapeutic properties of pharmaceutical and biological products for prevention and treatment of diseases, disorders and conditions; medical services; veterinary services; hygienic care for human beings; hygienic care for animals |
| Goods and Services | Apparatus for tumour diagnosis, namely, Imaging Mass Cytometry (IMC) apparatus; medical apparatus, namely, spectrometers for machine learning-based spectrum analysis of human blood plasma; Multiplex protein imaging scanners for medical diagnosis; apparatus for clinical diagnosis, namely, digital imaging device; spectrum analyzers for use in medical diagnosis; apparatus used in implementing diagnosis tests designed to detect abnormal genetic mutations in proteins, namely, spatial proteomics tools; diagnostic oncology apparatus for medical use, namely, digital imaging device; diagnostic, examination, and monitoring equipment, namely, multiplex protein imaging equipment; medical test kits comprising tissue sampling equipment for the use in oncology for cancer screening; medical test kits comprising tissue analysis tools for individual diagnosis in the field of cancer therapy |
| Goods and Services | Medical research in the field of cancer; medical research in the field of cancer diagnosis; Medical research in the field of proteomics; Medical research in the field of oncology; Medical research in the field of oncological diagnostics; technical data analysis services, namely, medical data analysis for cancer diagnostics; software-as-a-service (SaaS) featuring software for use in cancer diagnosis; platform-as-a-service (PaaS) featuring software for use in cancer diagnosis; software-as-a-service (SaaS) featuring software for cell analysis for use in oncology; platform-as-a-service (PaaS) featuring software for cell analysis for use in oncology; software-as-a-service (SaaS) featuring software for medical and scientific research in the field of cancer treatment and diagnosis; platform-as-a-service (PaaS) featuring software for medical and scientific research in the field of cancer treatment and diagnosis; software-as-a-service (SaaS) featuring software using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis; Platform as- a-service (PaaS) featuring software using machine learning in the field of medical diagnosis and research, particularly for cancer research, treatment and diagnosis; software-as-a-service (SaaS) featuring software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; platform-as-a-service (PaaS) featuring software for the analysis of medical data, particularly for cancer research, treatment and diagnosis; software as-a-service (SaaS) featuring software for the digital representation of tumours and tumour features; platform-as-a-service (PaaS) featuring software for the digital representation of tumours and tumour features; software as-a-service (SaaS) featuring software for high- resolution digital image representation of the molecular composition of cellular anomalies; platform-as-a-service (PaaS) featuring software for high-resolution digital image representation of the molecular composition of cellular anomalies; software as-a-service (SaaS) featuring software for high- resolution digital image representation of digital tumors; platform-as-a-service (PaaS) featuring software for high- resolution digital image representation of digital tumors |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 12, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 12, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 12, 2024 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 12, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 12, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 12, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Navignostics AG |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 84 - NOT AVAILABLE |
| Address | CH |
| Party Name | Andrea Jacobs |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 98 - Unknown |
| Address | CH |
| Event Date | Event Description |
| Thursday, April 18, 2024 | APPLICATION FILING RECEIPT MAILED |
| Saturday, July 6, 2024 | CHANGE OF OWNER RECEIVED FROM IB |
| Friday, September 6, 2024 | ASSIGNED TO EXAMINER |
| Thursday, April 11, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, April 12, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, September 30, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, October 1, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, October 4, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, October 4, 2024 | REFUSAL PROCESSED BY MPU |
| Wednesday, April 2, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 2, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 2, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, October 26, 2024 | REFUSAL PROCESSED BY IB |